UPDATE: Acurx Says 'Using samples from Phase 1 healthy volunteers and a novel OMICS analysis approach, ibezapolstat differed favorably from vancomycin in microbiota abundance including a marked increase in Proteobacteria and Fusobacterium, concentration'